These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 11086227
1. Influence of the substitution of 11-methylene, delta(15), and/or 18-methyl groups in norethisterone on receptor binding, transactivation assays and biological activities in animals. Deckers GH, Schoonen WG, Kloosterboer HJ. J Steroid Biochem Mol Biol; 2000 Oct; 74(3):83-92. PubMed ID: 11086227 [Abstract] [Full Text] [Related]
2. Contraceptive progestins. Various 11-substituents combined with four 17-substituents: 17alpha-ethynyl, five- and six-membered spiromethylene ethers or six-membered spiromethylene lactones. Schoonen WG, Deckers G, de Gooijer ME, de Ries R, Mathijssen-Mommers G, Hamersma H, Kloosterboer HJ. J Steroid Biochem Mol Biol; 2000 Oct; 74(3):109-23. PubMed ID: 11086230 [Abstract] [Full Text] [Related]
3. Hormonal properties of norethisterone, 7alpha-methyl-norethisterone and their derivatives. Schoonen WG, Deckers GH, de Gooijer ME, de Ries R, Kloosterboer HJ. J Steroid Biochem Mol Biol; 2000 Nov 15; 74(4):213-22. PubMed ID: 11162927 [Abstract] [Full Text] [Related]
6. 5alpha-reduction of norethisterone enhances its binding affinity for androgen receptors but diminishes its androgenic potency. Lemus AE, Enríquez J, García GA, Grillasca I, Pérez-Palacios G. J Steroid Biochem Mol Biol; 1997 Jan 15; 60(1-2):121-9. PubMed ID: 9182866 [Abstract] [Full Text] [Related]
7. Transactivation of progestin- and estrogen-responsive promoters by 19-nor progestins in African Green Monkey Kidney CV1 cells. Pasapera AM, Gutiérrez-Sagal R, García-Becerra R, Ulloa-Aguirre A, Savouret JF. Endocrine; 2001 Dec 15; 16(3):217-25. PubMed ID: 11954666 [Abstract] [Full Text] [Related]
8. Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptives. Kloosterboer HJ, Vonk-Noordegraaf CA, Turpijn EW. Contraception; 1988 Sep 15; 38(3):325-32. PubMed ID: 3139361 [Abstract] [Full Text] [Related]
10. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential. Fuhrmann U, Krattenmacher R, Slater EP, Fritzemeier KH. Contraception; 1996 Oct 15; 54(4):243-51. PubMed ID: 8922878 [Abstract] [Full Text] [Related]
11. Characterization of the novel progestin gestodene by receptor binding studies and transactivation assays. Fuhrmann U, Slater EP, Fritzemeier KH. Contraception; 1995 Jan 15; 51(1):45-52. PubMed ID: 7750284 [Abstract] [Full Text] [Related]
12. Synthesis and biological effect of halogen substituted phenyl acetic acid derivatives of progesterone as potent progesterone receptor antagonists. Cabeza M, Bratoeff E, Gómez G, Heuze I, Rojas A, Ochoa M, Palomino MA, Revilla C. J Steroid Biochem Mol Biol; 2008 Sep 15; 111(3-5):232-9. PubMed ID: 18625316 [Abstract] [Full Text] [Related]
13. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Muhn P, Fuhrmann U, Fritzemeier KH, Krattenmacher R, Schillinger E. Ann N Y Acad Sci; 1995 Jun 12; 761():311-35. PubMed ID: 7625729 [Abstract] [Full Text] [Related]
14. Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins. Phillips A, Demarest K, Hahn DW, Wong F, McGuire JL. Contraception; 1990 Apr 12; 41(4):399-410. PubMed ID: 2335104 [Abstract] [Full Text] [Related]
15. Comparison of 7α-methyl-19-nortestosterone effectiveness alone or combined with progestins on androgen receptor mediated-transactivation. García-Becerra R, Ordaz-Rosado D, Noé G, Chávez B, Cooney AJ, Larrea F. Reproduction; 2012 Feb 12; 143(2):211-9. PubMed ID: 22065861 [Abstract] [Full Text] [Related]
16. The influence of structural modification on progesterone and androgen receptor binding of norethisterone. Correlation with nuclear magnetic resonance signals. Hoppen HO, Hammann P. Acta Endocrinol (Copenh); 1987 Jul 12; 115(3):406-12. PubMed ID: 3618086 [Abstract] [Full Text] [Related]
17. Mechanisms of hormonal and antihormonal action of contraceptive progestins at the molecular level. Pérez-Palacios G, Cerbón MA, Pasapera AM, Castro JI, Enríquez J, Vilchis F, García GA, Moralí G, Lemus AE. J Steroid Biochem Mol Biol; 1992 Mar 12; 41(3-8):479-85. PubMed ID: 1562519 [Abstract] [Full Text] [Related]
18. Validation of in vitro screening models for progestagenic activities: inter-assay comparison and correlation with in vivo activity in rabbits. Sonneveld E, Pieterse B, Schoonen WG, van der Burg B. Toxicol In Vitro; 2011 Mar 12; 25(2):545-54. PubMed ID: 21130152 [Abstract] [Full Text] [Related]
19. Mechanism of action of levonorgestrel: in vitro metabolism and specific interactions with steroid receptors in target organs. Lemus AE, Vilchis F, Damsky R, Chávez BA, García GA, Grillasca I, Pérez-Palacios G. J Steroid Biochem Mol Biol; 1992 Mar 12; 41(3-8):881-90. PubMed ID: 1562565 [Abstract] [Full Text] [Related]
20. Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines. Schoonen WG, Joosten JW, Kloosterboer HJ. J Steroid Biochem Mol Biol; 1995 Dec 12; 55(3-4):423-37. PubMed ID: 8541240 [Abstract] [Full Text] [Related] Page: [Next] [New Search]